There are five actions that I would bring to the committee's attention. First, if someone gets an approval from us in a clinical trial, we encourage them to register the clinical trial at a publicly available registry endorsed by the WHO. As the business becomes increasingly international, we think this is helpful for patients.
Secondly, we require that the product monographs be posted. Individual consumers are looking for drugs that are on the market to understand if they might be interested in taking them. Those are in a searchable database that Health Canada has. We are working to make, as my colleague mentioned, the labels easier to read, because sometimes the monographs can be—